Clinical Trial

Weight Loss in Adults Using Semaglutide (Real-world Study)

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician.
Trial Details
NCT Number NCT07627074
Lead Sponsor Novo Nordisk A/S
Conditions Overweight, Obesity
Enrollment 35,000 participants
Start Date 2026-05-12
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04